| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17a24b5e885957f129b82d23d8cddc24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b3c964f224f9a0aac2f7b0b73d55e84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bc8291fd77823a4ff0dafcc8c37fc78 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L97-00 |
| filingDate |
2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35a92f94277bf8e6672ac0f5ac9cdae2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bc0517ddb4075697fc56a884ff5bd5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dce2cf64ae593469d57db5acecd55d5 |
| publicationDate |
2007-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7238374-B2 |
| titleOfInvention |
Process and substances for the release of a growth-regulating factor from endothelial cells |
| abstract |
Endothelial cells have the natural property of releasing soluble factors into the fluid surrounding them, said factors altering the behavior of immune cells. In cell systems containing at least endothelial cells, the release of this type of factor, which promotes the proliferation of resting and weakly activated lymphocytes and at the same time inhibits the proliferation of highly activated lymphocytes and transformed lymphoblasts without impairing their other vital functions, is induced by administration of pentacyclic oxindole alkaloids but inhibited by the concurrent administration of tetracyclic oxindole alkaloids. |
| priorityDate |
1997-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |